Molecular imaging using Ga-68-HER2 PET/CT provides a whole-body visualization of receptor expression that traditional anatomical scans simply cannot match. This breakthrough addresses a significant clinical hurdle in managing HER2-positive breast cancer, which represents nearly a quarter of all
Traditional imaging methods like DECT and MRI offer high accuracy for gout diagnosis but remain limited by their high cost and lack of portability. In the management of advanced gout, the presence of tophi—dense accumulations of monosodium urate crystals—serves as a definitive marker of disease
Managing the spread of cancer to the vertebral column remains one of the most significant clinical hurdles for oncologists today, as the risk of neurological damage often limits the ability to perform invasive diagnostic procedures. Significant differences in protein concentration and pH levels
Total-body PET/CT represents a fundamental shift in medical physics, moving the industry away from the rigid trade-offs between image quality and scanning speed. For decades, the nuclear medicine community has been constrained by the physical limitations of short-axial field-of-view (SA-FOV)
Advanced machine learning models are now capable of interpreting preoperative MRI scans to identify highly aggressive liver tumors before a surgical incision is ever made. This breakthrough, originating from a significant multicenter research initiative in China, represents a pivotal shift in how
Effective breast cancer management now relies on imaging to track the patient's response to therapy and adjust treatment plans in real time. This dynamic approach marks a significant departure from the static, population-based screening models that dominated the medical landscape for decades. As
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50